Published in BMC Cancer on March 16, 2015
Inflammation, Immune Activation, and Antiretroviral Therapy in HIV. Curr HIV/AIDS Rep (2017) 0.76
Risk Of Colorectal Cancer And Associated Mortality In Hiv: A Systematic Review And Meta-Analysis. J Acquir Immune Defic Syndr (2017) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
A review of human carcinogens--Part B: biological agents. Lancet Oncol (2009) 13.85
Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology (2004) 8.36
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology (1999) 5.55
Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis (2001) 5.27
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med (2010) 4.30
A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr (2009) 3.76
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet (2014) 3.31
AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst (2007) 3.28
HIV infection and the risk of cancers with and without a known infectious cause. AIDS (2009) 3.13
Kaposi's sarcoma in homosexual men-a report of eight cases. Lancet (1981) 2.75
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol (2005) 2.27
Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer. Adv Cancer Res (2002) 1.78
Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis (2010) 1.78
Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy. AIDS (2001) 1.72
Causes of oral cancer--an appraisal of controversies. Br Dent J (2009) 1.65
Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. Br J Cancer (2006) 1.53
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer (2012) 1.41
Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res (2005) 1.27
Cancer screening in patients infected with HIV. Curr HIV/AIDS Rep (2011) 1.21
Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in Asia. Cancer Epidemiol Biomarkers Prev (2009) 1.20
Human immunodeficiency virus-associated adenocarcinoma of the colon: clinicopathologic findings and outcome. Clin Colorectal Cancer (2009) 1.08
Human papillomavirus infection in HIV-infected persons. Top HIV Med (2007) 1.02
Cutaneous malignancies among HIV-infected persons. Arch Intern Med (2009) 0.96
Triple negative breast carcinoma is a prognostic factor in Taiwanese women. BMC Cancer (2009) 0.96
Lung cancer in HIV Infection. Clin Lung Cancer (2011) 0.95
Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study. PLoS One (2014) 0.92
AIDS: the early years and CDC's response. MMWR Surveill Summ (2011) 0.91
Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence. Eur J Med Res (2011) 0.91
Breast cancer among HIV-infected patients: the experience of the European Institute of Oncology. J Surg Oncol (2005) 0.83
Non-AIDS-defining cancer in HIV-infected people. Hematol Oncol Clin North Am (2003) 0.82
HIV-infected patients with anal carcinoma who subsequently developed oral squamous cell carcinoma: report of 2 cases. J Int Assoc Physicians AIDS Care (Chic) (2008) 0.78